ArticlePloS one2019

[Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti-CTLA-4 antibody in a mouse model.

Tomomi Nakayama Iwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.